CANMAT Flashcards
MDD + ADHD: first line pharmacoTx
Bupropion
antidepresseur + long life stimulant
antidepresseur + CBT
MDD + ADHD : 2nd line pharmacoTx
desipramine
nortriptylline
Effexor
BD + ADHD : 1st line pharmacoTx
Bupropion
BD + ADHD: 2nd line pharmacoTx
methyphenidate
modafinil
CBT
mood disorder + personnality disorder: management
no level of evidence
screen PD for MD and vise versa
assess in resitant MD
reassess after MD episode
collateral Hx for co-occurence + longitudinal Hx
Tx of both, Axis I first
post-stroke Depression; CANMAT recommendations
1st line - Citalopram (level 2)
2nd line - Nortriptylin (level 1)
3rd line - Amitryptyline - Trazodone - ECT
avoid
Paroxetine (inh CYP 2D6)
Fluoxetine (inh CYP 1A2, 2D6, 3A4, 2C)
Antipsychotics
MD + CVD: recommendations
screen for Depression
Treat with SSRI/SNRI (level 2)
prévalence de syndrome métabolique chez MD
20-65%
obesity management recommendations
1st line: Metformin
2nd line: Topiramate (in BD)
Bulimia management
in BD: Lamotrigine
Précautions chez Pts avec hypertension
effet des psychotropes sur TA
SSRI - neutral
SNRI - increase
bupropion - increase
mirtazapine / trazodone / nefazodone - neutral
MAOI - decrease
Li/antipsychotics/mood stabilizers - neutral
mood disorders and cancer: recommendations
no specific recommendations for phramacoTx or PsychoTx
mood disorders and HIV: recommendations
try SSRI first (fluoxetine, paroxetine, sertraline, citalopram, escitalopram) Citalopram et escitalopram - less drug-drug interaction with HAART
then TCA
stimulants (level 2): dextroamphetamine, methylphenidate
psychoTX (CCT, IPT, supportive, group)
recommandations concernant ostéoporose
pts >40 ans avec 2ans d’antidepresseur - screen bone density
Pts sur long term mood stabilizer - screen
Pts >50 ans - Vit D
Mood disorder + epilepsy: recommandations
- control seizures
- post surgery Pts (anterotemoral lobectomy) are at risk of D
- avoid AEDs with depressogenic properties (GABA with no serotoninergic effect) - lower dose or switch to AED with mood stabilizer effect - lamictal, epival, carbamazepine
- if antidepressant - diminuer CYP interaction - citalopram, escitalopram, sertraline; if failed - effexor; TCA and MAOI - only in resistant cases
- lamotrigine en monoTx or adjunct
- CBT + antidepresseur
- ECT
CANMAT MAB et comorbidité 2012
1 line: Gabapentin, quetiapine
2 line: epival, Lamotrigine, IRSR, olanzapine, Olanzapine - Fluoxetine
3 line: Li, Risperdal, aripiprazole, pregabaline, benzos
CAT 1ere ligne en depression
modéré-sévère:
pharmaco (cipralex, celexa, zoloft, effexor, remeron, fluvoxamine, paroxétine, desvenlafaxine, duloxetine, bupropion, vortioxétine)
adjuvant 1ere ligne - aripiprazole, quetiapine, risperidone
legère:
psychoTx (aigue - CBT, IPT, BA; maintien - CBT, MBCT)
exercice
EDC saisonier - luminoTx
effets secondaires des AD
QT, chute, fracture hypoNa, risque saignements GI
pharmacoTx selon specificateur de la D
catatonie - benzo
psychotique - ajouter AP
mixte - lurazidone, ziprazidone
dysfonction cognitive - vortioxetine, bupropion, duloxetine,
alteration sommeil - agomelatine, mirtazapine, seroquel, trazodone